Proposed Collection; 60-Day Comment Request; Generic Clearance for the Collection of Qualitative Feedback on Agency Service Delivery (National Institute Allergy and Infectious Diseases), 94750-94751 [2024-27902]

Download as PDF 94750 Federal Register / Vol. 89, No. 230 / Friday, November 29, 2024 / Notices publishing additional ICPGs addressing other health care industry segments in the future. OIG welcomes written and specific feedback from the health care community and other stakeholders in connection with the GCPG and the Nursing Facility ICPG. Any such feedback can be submitted by email to Compliance@oig.hhs.gov. The receipt of any feedback does not obligate OIG to take action, including responding to the feedback, making the feedback public, or issuing or revising public guidance. III. Paperwork Reduction Act of 1995 These resources contain no collection of information. Therefore, clearance by the Office of Management and Budget under the Paperwork Reduction Act of 1995 is not required. Christi A. Grimm, Inspector General. [FR Doc. 2024–28019 Filed 11–27–24; 8:45 am] BILLING CODE 4152–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Amended Notice of Meeting khammond on DSK9W7S144PROD with NOTICES Notice is hereby given of a change in the meeting of the Interdisciplinary Molecular Sciences and Training Integrated Review Group, Center for Scientific Review Special Emphasis Panel, December 5, 2024, 10 a.m. to December 5, 2024, 4 p.m., National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 which was published in the Federal Register on November 08, 2024, 89 FR 88789, Doc 2024–25937. This meeting is being amended to change the meeting start time from 10:00 a.m. to 8:00 a.m. to accommodate an increase in applications being discussed. The meeting is closed to the public. Dated: November 22, 2024. Miguelina Perez, Program Analyst, Office of Federal Advisory Committee Policy. DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meeting Proposed Collection; 60-Day Comment Request; Generic Clearance for the Collection of Qualitative Feedback on Agency Service Delivery (National Institute Allergy and Infectious Diseases) Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Diabetes and Digestive and Kidney Diseases Special Emphasis Panel; NIDDK High Risk Multi-Center Clinical Study Review Meeting. Date: January 22, 2025. Time: 10:00 a.m. to 12:00 p.m. Agenda: To review and evaluate grant applications. Address: National Institutes of Health, NIDDK, Democracy II, Suite 7000A, 6707 Democracy Boulevard, Bethesda, MD 20892. Meeting Format: Virtual Meeting. Contact Person: Michele L. Barnard, Ph.D., Scientific Review Officer, Review Branch, DEA, NIDDK, National Institutes of Health, Room 7343, 6707 Democracy Boulevard, Bethesda, MD 20817, (301) 594–8898, barnardm@extra.niddk.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.847, Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology and Hematology Research, National Institutes of Health, HHS) Dated: November 22, 2024. Miguelina Perez, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2024–28002 Filed 11–27–24; 8:45 am] BILLING CODE 4140–01–P [FR Doc. 2024–28001 Filed 11–27–24; 8:45 am] BILLING CODE 4140–01–P VerDate Sep<11>2014 21:22 Nov 27, 2024 Jkt 265001 PO 00000 Frm 00050 Fmt 4703 Sfmt 4703 AGENCY: National Institutes of Health, HHS. ACTION: Notice. In compliance with the requirement of the Paperwork Reduction Act of 1995 to provide opportunity for public comment on proposed data collection projects, the National Institute of Allergy and Infectious Diseases (NIAID) will publish periodic summaries of proposed projects to be submitted to the Office of Management and Budget (OMB) for review and approval. DATES: Comments regarding this information collection are best assured of having their full effect if received within 60 days of the date of this publication. FOR FURTHER INFORMATION CONTACT: To obtain a copy of the data collection plans and instruments, submit comments in writing, or request more information on the proposed project, contact: Sarah Hijaz, Health Science Policy Analyst, Office of Strategic Planning, Initiative Development and Analysis, 5601 Fishers Lane, Rockville, Maryland 20892 or call non-toll-free number (301)761–7790 or Email your request, including your address to: sarah.hijaz@nih.gov. Formal requests for additional plans and instruments must be requested in writing. SUPPLEMENTARY INFORMATION: Section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995 requires: written comments and/or suggestions from the public and affected agencies are invited to address one or more of the following points: (1) Whether the proposed collection of information is necessary for the proper performance of the function of the agency, including whether the information will have practical utility; (2) The accuracy of the agency’s estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; (3) Ways to enhance the quality, utility, and clarity of the information to be collected; and (4) Ways to minimizes the burden of the collection of information on those who are to respond, including the use of SUMMARY: E:\FR\FM\29NON1.SGM 29NON1 94751 Federal Register / Vol. 89, No. 230 / Friday, November 29, 2024 / Notices appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology. Proposed Collection Title: Generic Clearance for the Collection of Qualitative Feedback on Agency Service Delivery (NIAID), 0925–0668, Expiration Date 07/31/2025, EXTENSION, National Institute of Allergy and Infectious Diseases (NIAID). Need and Use of Information Collection: There are no changes being requested for this submission. The proposed information collection activity provides a means to garner qualitative customer and stakeholder feedback in an efficient, timely manner, in accordance with the Administration’s commitment to improving service delivery. By qualitative feedback we mean information that provides useful insights on perceptions and opinions but are not statistical surveys that yield quantitative results that can be generalized to the population of study. This feedback will provide information about the NIAID’s customer or stakeholder perceptions, experiences and expectations, provide an early warning of issues with service, or focus attention on areas where communication, training or changes in operations might improve delivery of products or services. These collections will allow for ongoing, collaborative and actionable communications between the NIAID and its customers and stakeholders. It will also allow feedback to contribute directly to the improvement of program management. OMB approval is requested for 3 years. There are no costs to respondents other than their time. The total estimated annualized burden hours over 3 years are 7200 (2400 per year). ESTIMATED ANNUALIZED BURDEN HOURS Number of respondents Type of collection Hours per response Total hours Customer satisfaction surveys ......................................................................... In-Depth Interviews (IDIs) or Small Discussion Groups .................................. Individual Brief Interviews ................................................................................ Focus Groups .................................................................................................. Pilot testing surveys ......................................................................................... Conferences and Training Pre- and Post-surveys .......................................... Website or Software Usability Tests ................................................................ 4000 20 40 30 20 500 20 1 1 1 1 1 1 1 30/60 90/60 15/60 2 30/60 30/60 2 2000 30 10 60 10 250 40 Total .......................................................................................................... ........................ 4630 ........................ 2400 Dated: November 22, 2024. Brandie K. Taylor Bumgardner, Project Clearance Liaison, National Institutes of Allergy and Infectious Diseases, National Institutes of Health. [FR Doc. 2024–27902 Filed 11–27–24; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meeting khammond on DSK9W7S144PROD with NOTICES Annual frequency per response Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Initial Review Group; Kidney, Urologic and Hematologic Diseases D Study Section Hoffert_2/25–27/2025. Date: February 25–27, 2025. Time: 5 p.m. to 5 p.m. Agenda: To review and evaluate grant applications. Address: National Institutes of Health, NIDDK, Democracy II, Suite 7000A, 6707 Democracy Boulevard, Bethesda, MD 20892. Meeting Format: Virtual Meeting. Contact Person: Jason D. Hoffert, Ph.D., Scientific Review Officer, Review Branch, DEA, NIDDK, National Institutes of Health, Room 7343, 6707 Democracy Boulevard, Bethesda, MD 20817, 301–496–9010, hoffertj@niddk.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.847, Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology and Hematology Research, National Institutes of Health, HHS). Dated: November 22, 2024. Miguelina Pere,z Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2024–28000 Filed 11–27–24; 8:45 am] BILLING CODE 4140–01–P Name of Committee: National Institute of Diabetes and Digestive and Kidney Diseases VerDate Sep<11>2014 21:22 Nov 27, 2024 Jkt 265001 PO 00000 Frm 00051 Fmt 4703 Sfmt 4703 DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Mental Health; Notice of Closed Meeting Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Mental Health Special Emphasis Panel; BRAIN Initiative K99/R00 Application Review. Date: December 13, 2024. Time: 1 p.m. to 3 p.m. Agenda: To review and evaluate grant applications. Address: National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852. Meeting Format: Virtual Meeting. E:\FR\FM\29NON1.SGM 29NON1

Agencies

[Federal Register Volume 89, Number 230 (Friday, November 29, 2024)]
[Notices]
[Pages 94750-94751]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-27902]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Proposed Collection; 60-Day Comment Request; Generic Clearance 
for the Collection of Qualitative Feedback on Agency Service Delivery 
(National Institute Allergy and Infectious Diseases)

AGENCY: National Institutes of Health, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: In compliance with the requirement of the Paperwork Reduction 
Act of 1995 to provide opportunity for public comment on proposed data 
collection projects, the National Institute of Allergy and Infectious 
Diseases (NIAID) will publish periodic summaries of proposed projects 
to be submitted to the Office of Management and Budget (OMB) for review 
and approval.

DATES: Comments regarding this information collection are best assured 
of having their full effect if received within 60 days of the date of 
this publication.

FOR FURTHER INFORMATION CONTACT: To obtain a copy of the data 
collection plans and instruments, submit comments in writing, or 
request more information on the proposed project, contact: Sarah Hijaz, 
Health Science Policy Analyst, Office of Strategic Planning, Initiative 
Development and Analysis, 5601 Fishers Lane, Rockville, Maryland 20892 
or call non-toll-free number (301)761-7790 or Email your request, 
including your address to: [email protected]. Formal requests for 
additional plans and instruments must be requested in writing.

SUPPLEMENTARY INFORMATION: Section 3506(c)(2)(A) of the Paperwork 
Reduction Act of 1995 requires: written comments and/or suggestions 
from the public and affected agencies are invited to address one or 
more of the following points: (1) Whether the proposed collection of 
information is necessary for the proper performance of the function of 
the agency, including whether the information will have practical 
utility; (2) The accuracy of the agency's estimate of the burden of the 
proposed collection of information, including the validity of the 
methodology and assumptions used; (3) Ways to enhance the quality, 
utility, and clarity of the information to be collected; and (4) Ways 
to minimizes the burden of the collection of information on those who 
are to respond, including the use of

[[Page 94751]]

appropriate automated, electronic, mechanical, or other technological 
collection techniques or other forms of information technology.
    Proposed Collection Title: Generic Clearance for the Collection of 
Qualitative Feedback on Agency Service Delivery (NIAID), 0925-0668, 
Expiration Date 07/31/2025, EXTENSION, National Institute of Allergy 
and Infectious Diseases (NIAID).
    Need and Use of Information Collection: There are no changes being 
requested for this submission. The proposed information collection 
activity provides a means to garner qualitative customer and 
stakeholder feedback in an efficient, timely manner, in accordance with 
the Administration's commitment to improving service delivery. By 
qualitative feedback we mean information that provides useful insights 
on perceptions and opinions but are not statistical surveys that yield 
quantitative results that can be generalized to the population of 
study. This feedback will provide information about the NIAID's 
customer or stakeholder perceptions, experiences and expectations, 
provide an early warning of issues with service, or focus attention on 
areas where communication, training or changes in operations might 
improve delivery of products or services. These collections will allow 
for ongoing, collaborative and actionable communications between the 
NIAID and its customers and stakeholders. It will also allow feedback 
to contribute directly to the improvement of program management.
    OMB approval is requested for 3 years. There are no costs to 
respondents other than their time. The total estimated annualized 
burden hours over 3 years are 7200 (2400 per year).

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                      Annual
               Type of collection                    Number of     frequency per     Hours per      Total hours
                                                    respondents      response        response
----------------------------------------------------------------------------------------------------------------
Customer satisfaction surveys...................            4000               1           30/60            2000
In-Depth Interviews (IDIs) or Small Discussion                20               1           90/60              30
 Groups.........................................
Individual Brief Interviews.....................              40               1           15/60              10
Focus Groups....................................              30               1               2              60
Pilot testing surveys...........................              20               1           30/60              10
Conferences and Training Pre- and Post-surveys..             500               1           30/60             250
Website or Software Usability Tests.............              20               1               2              40
                                                 ---------------------------------------------------------------
    Total.......................................  ..............            4630  ..............            2400
----------------------------------------------------------------------------------------------------------------


    Dated: November 22, 2024.
Brandie K. Taylor Bumgardner,
Project Clearance Liaison, National Institutes of Allergy and 
Infectious Diseases, National Institutes of Health.
[FR Doc. 2024-27902 Filed 11-27-24; 8:45 am]
BILLING CODE 4140-01-P


This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.